Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Anavex Life Sciences Corp (AVXL) Com Stk USD0.001

Sell:$5.15 Buy:$5.16 Change: $0.02 (0.39%)
NASDAQ:0.22%
Market closed |  Prices as at close on 23 November 2020 | Switch to live prices |
Sell:$5.15
Buy:$5.16
Change: $0.02 (0.39%)
Market closed |  Prices as at close on 23 November 2020 | Switch to live prices |
Sell:$5.15
Buy:$5.16
Change: $0.02 (0.39%)
Market closed |  Prices as at close on 23 November 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain and various types of cancer. Its research and development pipeline includes a clinical drug candidate and various compounds in different stages of pre-clinical study. Its product pipeline also includes ANAVEX 2-73, ANAVEX 3-71, ANAVEX 1-41, ANAVEX 1037 and ANAVEX 1066. The Company's SIGMACEPTOR Discovery Platform produces small molecule drug candidates with modes of action, based on its understanding of sigma receptors. ANAVEX 1-41 is a sigma-1 agonist. ANAVEX 1066 is a mixed sigma-1/sigma-2 ligand. As of September 30, 2016, the Company had not generated any revenues from its operations.

Contact details

Address:
51 W 52nd St Fl 7th
NEW YORK
10019-6163
United States
Telephone:
+1 (800) 6893939
Website:
https://www.anavex.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AVXL
ISIN:
US0327973006
Market cap:
$311.19 million
Shares in issue:
60.19 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Christopher Missling
    President, Chief Executive Officer, Secretary, Director
  • Sandra Boenisch
    Principal Financial Officer, Treasurer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.